PlainRecalls
FDA Drug Low Class III Terminated

Fexofenadine Hydrochloride Tablets, USP 60 mg, Allergy, Non-Drowsy, Antihistamine, 100 tablets (10 X 10) per UD Cartons, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, USA, NDC 51079-547-20

Reported: May 27, 2015 Initiated: March 26, 2015 #D-1083-2015

Product Description

Fexofenadine Hydrochloride Tablets, USP 60 mg, Allergy, Non-Drowsy, Antihistamine, 100 tablets (10 X 10) per UD Cartons, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, USA, NDC 51079-547-20

Reason for Recall

Failed Impurities/Degradation Specifications: the manufacturer, recalled product due to slightly above specification results for a Related Compound during routine stability testing

Details

Units Affected
1,363 UD Cartons
Distribution
Nationwide
Location
Rockford, IL

Frequently Asked Questions

What product was recalled?
Fexofenadine Hydrochloride Tablets, USP 60 mg, Allergy, Non-Drowsy, Antihistamine, 100 tablets (10 X 10) per UD Cartons, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, USA, NDC 51079-547-20. Recalled by Mylan Institutional, Inc. (d.b.a. UDL Laboratories). Units affected: 1,363 UD Cartons.
Why was this product recalled?
Failed Impurities/Degradation Specifications: the manufacturer, recalled product due to slightly above specification results for a Related Compound during routine stability testing
Which agency issued this recall?
This recall was issued by the FDA Drug on May 27, 2015. Severity: Low. Recall number: D-1083-2015.